Regulatory effect of catalpol from Radix Rehmanniae on M2 receptor density in M2 receptor transfected CHO cells

Chinese Pharmacological Bulletin

Volumn 22, Issue 12, 2006, Pages 1462-1466

  Wang, Jin Hong ^a   Sun, Qi Xiang ^a   Xia, Zong Qin ^a   Hu, Ya Er ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Catalpol; CHOm2 cells; M2 receptor density

Indexed keywords

ACETYLCHOLINESTERASE; CATALPOL; MUSCARINIC M2 RECEPTOR; SODIUM CHLORIDE;

ANIMAL CELL; ARTICLE; COLORIMETRY; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME ACTIVITY; MASS SPECTROMETRY; NONHUMAN;

EID: 33847012190     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Du H Q, Guo X Y, Zhao X, et al. Research of rehmanniae radix [M]// Lou Z Q, Qin B. Species systematization and quality evalution of commonly used Chinese traditional drugs. North-China edition, volume II. Beijing: Peking medical university publishing house, 1995: 839.
2. Isao Kitagawa, Masayuki Yoshikawa. Chemical constituents of rehmanniae radix, corni fructus, dioscoreae rhizoma [M]. Modern Eastern Medicine, 1986, 7(3): 55-62.
3. Inouye H. Purgative activities of iridoid glucosides[J]. Planta Medica, 1974, 25(3): 285.
4. Yamazaki M, Chiba K, Mohri T. Neuritogenic effect of natural iridoid compounds on PC 12h cells and its possible relation to signaling protein kinases[J]. Biol Pharm Bull, 1996, 19(6): 791-5.
5. Li D Q, Li Y, Liu Y X, et al. Catalpol prevents the loss of CA1 hippocampal neurons and reduces working errors in gerbils after ischemia-reperfusion injury[J]. Toxicon, 2005, 46(8): 845-51.
6. Jiang B, Liu H J, Bao M Y, et al. Catalpol inhibits apoptosis in hydrogen peroxide-induced PC12 cells by preventing cytochrome c release and inactivating of caspase cascade[J]. Toxicon, 2004, 43 (1): 53-9.
7. Liu Q F, Sun QX, Hu Y E, et al. Regulatory action of catalpol from radix rehmanniae on β-Adrenoceptor-cyclic AMP system[J]. J Radioimmunol, 2004, 17(5): 358-60.
8. Buckley N J, Bonner T I. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells[J]. Molecul Pharmacol, 1999, 35: 469-76.
9. 2 -receptor subtype[J]. Nuclear Techniques, 1999, 22(11): 642-6.
10. Hu Y E, Xin Z Q, Sun Q X, et al. A new approach to the pharmacological regulation of memory: sarsasapogenin improves memory by elevating the low muscarinic acetylcholine receptor density in brains of memory-deficit rat models[J]. Brain Res, 2005, 1060 (1-2): 26-39.
11. Svedberg M M, Bednar I, Nordberg A. Effect of subchronic galantamine treatment on neuron nicotinic and muscarinic receptor subtypers in transgenic mice overexpressing human acetylcholinesterase[J]. Neuropharmacology, 2004, 47: 558-71.
12. Winblad B, Jelic B. Long-term treatment of Alzheimer disease: efficacy and safety of acetylcholinesterase inhibitors[J]. Alzheimer Disease Associated Disorder, 2004, 18(Suppl) 1: S2-8.
13. Segal M, Auerbach J M. Muscarinic receptors involved in hippocampal plasticity[J]. Life Sci, 1997, 60: 1085-91.
14. 2 muscarinic acetylcholine receptor knock-out mice show deficits in behavioral flexibility, working memory, and hippocampal plasticity[J]. J Neurosci, 2004, 24: 10117-27.
15. Hu Y E, Sun Q X, Xia Z Q. The effect of ZMS, an active component of zhimu, on NGF and BDNF in brains of aged rats[J]. Chin Pharmacol Bull, 2003, 19(2): 149-51.
16. Zhang N Z, Hu Y E, Xia Z Q. The effect of ZDY101 and SZ201 on α-APP generation[J]. J Shanghai Jiaotong Univ(Med Sci), 2002, 22(4): 289.